News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BAUM CHARLES M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| BAUM CHARLES M (Interim CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 54,054 shares
@ $37, valued at
$2M
|
|
| 06/28/2023 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Granted 32,500 options to buy
@ $12.88, valued at
$418.6k
|
|
| 06/16/2023 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 19,650 shares
@ $0
Granted 27,350 options to buy
@ $2.47, valued at
$67.6k
|
|
| 06/12/2023 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 01/24/2023 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/05/2023 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 3,648 shares
@ $46.6, valued at
$170k
|
|
| 12/21/2022 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 53,618 shares
@ $0
Sold 9,092 shares
@ $40.4167, valued at
$367.5k
|
|
| 11/28/2022 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 69,256 shares
@ $100, valued at
$6.9M
Exercised 69,256 options to buy
@ $17.41, valued at
$1.2M
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 19,500 options to buy
@ $13.56, valued at
$264.4k
|
|
| 01/18/2022 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 25,543 shares
@ $0
Sold 2,517 shares
@ $120.4821, valued at
$303.3k
Granted 42,325 options to buy
@ $124.31, valued at
$5.3M
Exercised 3,703 options to buy
@ $27, valued at
$100k
|
|
| 01/06/2022 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 4,045 shares
@ $147.73, valued at
$597.6k
Sold 69 shares
@ $149.085, valued at
$10.3k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Exercised 2,292 options to buy
@ $5.4, valued at
$12.4k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 9,888 shares
@ $233.4289, valued at
$2.3M
Sold 22,932 shares
@ $234.2577, valued at
$5.4M
Sold 493 shares
@ $235.2042, valued at
$116k
Sold 4,250 shares
@ $236.1722, valued at
$1M
Sold 2,020 shares
@ $237.255, valued at
$479.3k
Sold 100 shares
@ $238.755, valued at
$23.9k
Sold 317 shares
@ $240.23, valued at
$76.2k
Exercised 40,000 options to buy
@ $8.49, valued at
$339.6k
|
|
| 10/23/2020 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Disposed/sold 9,667 shares
@ $0
Disposed/sold 46,117 options to buy
@ $0
Disposed/sold 3,718 restricted stock units
@ $0 |
|
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 3,718 shares
@ $0
Granted 6,540 options to buy
@ $33.62, valued at
$219.9k
|
|
| 04/28/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Exercised 557 options to buy
@ $5.4, valued at
$3k
|
|
| 04/20/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 10,526 shares
@ $89.5932, valued at
$943.1k
Sold 25,184 shares
@ $90.4129, valued at
$2.3M
Sold 4,290 shares
@ $91.6299, valued at
$393.1k
Exercised 40,000 options to buy
@ $8.49, valued at
$339.6k
|
|
| 03/30/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Exercised 2,291 options to buy
@ $5.4, valued at
$12.4k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Exercised 2,291 options to buy
@ $5.4, valued at
$12.4k
Exercised 2,396 options to buy
@ $24.99, valued at
$59.9k
|
|
| 01/07/2020 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 80,000 options to buy
@ $113.2, valued at
$9.1M
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2019 |
4
| BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 11,843 shares
@ $85.0288, valued at
$1M
Sold 28,446 shares
@ $85.8853, valued at
$2.4M
Sold 3,619 shares
@ $86.578, valued at
$313.3k
Sold 4,544 shares
@ $88.241, valued at
$401k
Sold 1,622 shares
@ $89.2434, valued at
$144.8k
Sold 1,736 shares
@ $91.1156, valued at
$158.2k
Exercised 51,810 options to buy
@ $8.5, valued at
$440.4k
Exercised 2 options to buy
@ $5.4, valued at
$10.8
Exercised 556 options to buy
@ $24.99, valued at
$13.9k
|
|
|
|
|